They aren’t designed, you can’t help perceiving one anyway, and that makes them an engineering problem almost no one is solving. The post Where Does an AI’s Personality Actually Come From? appeared first on Towards Data Science. Read More

Nature Medicine, Published online: 09 July 2026; doi:10.1038/s41591-026-04525-0 A phase 1/2 trial of an off-the-shelf stem cell-derived dopaminergic progenitor therapy demonstrated a favorable 12-month safety profile, with no graft-related adverse events, dyskinesias or tumor formation, although risks were associated with the immunosuppression regimen. Read More

Nature Medicine, Published online: 09 July 2026; doi:10.1038/s41591-026-04512-5 The immune-privileged environment of the inner ear permits sequential bilateral gene therapy for one form of congenital deafness, which adds to growing evidence of the feasibility, safety and efficacy of this innovative curative treatment. Read More

Nature Medicine, Published online: 09 July 2026; doi:10.1038/s41591-026-04490-8 The 2024 revision of the McDonald diagnostic criteria is an important step toward earlier and more inclusive diagnosis of multiple sclerosis. Realizing its full potential will require continued refinement of biomarkers, disease stratification and clinical trial approaches. Read More

Nature Medicine, Published online: 09 July 2026; doi:10.1038/s41591-026-04538-9 In phase 1b/2 trial, the treatment of patients with metastatic KRASG12D-mutant pancreatic cancer, the intravenously delivered KRAS-G12D inhibitor HRS-4642 plus nab-paclitaxel and gemcitabine led to encouraging clinical response rates that support investigation in larger trials. Read More